Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs Weekend Atropine for Amblyopia
NCT00094614Phase 4Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jun 2002
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of atropine in amblyopia (2 arms), sponsored by Jaeb Center for Health Research. Primary endpoint: Visual Acuity Outcome in the Amblyopic Eye at 17 weeks. Started Jun 2002; status: completed.
02
Drugs
atropine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT00094614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094614.